Literature DB >> 23250412

Delivery of chemotherapeutic drugs in tumour cell-derived microparticles.

Ke Tang1, Yi Zhang, Huafeng Zhang, Pingwei Xu, Jing Liu, Jingwei Ma, Meng Lv, Dapeng Li, Foad Katirai, Guan-Xin Shen, Guimei Zhang, Zuo-Hua Feng, Duyun Ye, Bo Huang.   

Abstract

Cellular microparticles are vesicular plasma membrane fragments with a diameter of 100-1,000 nanometres that are shed by cells in response to various physiological and artificial stimuli. Here we demonstrate that tumour cell-derived microparticles can be used as vectors to deliver chemotherapeutic drugs. We show that tumour cells incubated with chemotherapeutic drugs package these drugs into microparticles, which can be collected and used to effectively kill tumour cells in murine tumour models without typical side effects. We describe several mechanisms involved in this process, including uptake of drug-containing microparticles by tumour cells, synthesis of additional drug-packaging microparticles by these cells that contribute to the cytotoxic effect and the inhibition of drug efflux from tumour cells. This study highlights a novel drug delivery strategy with potential clinical application.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250412     DOI: 10.1038/ncomms2282

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  57 in total

1.  Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.

Authors:  Kerby Shedden; Xue Tao Xie; Parthapratim Chandaroy; Young Tae Chang; Gustavo R Rosania
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

Review 2.  Potential neurotoxicity of nanoparticles.

Authors:  Yu-Lan Hu; Jian-Qing Gao
Journal:  Int J Pharm       Date:  2010-04-28       Impact factor: 5.875

3.  Nanohazards: knowledge is our first defence.

Authors:  Amanda S Barnard
Journal:  Nat Mater       Date:  2006-04       Impact factor: 43.841

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.

Authors:  Anirudh J Ullal; Charles F Reich; Megan Clowse; Lisa G Criscione-Schreiber; Martin Tochacek; Marc Monestier; David S Pisetsky
Journal:  J Autoimmun       Date:  2011-03-03       Impact factor: 7.094

6.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

7.  The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.

Authors:  Yoshifumi Takei; Misato Takigahira; Keichiro Mihara; Yuzo Tarumi; Kazuyoshi Yanagihara
Journal:  Cancer Res       Date:  2010-12-17       Impact factor: 12.701

Review 8.  Advances in nano drugs for cancer chemotherapy.

Authors:  Imran Ali; K Salim; Mohmad A Rather; Waseem A Wani; Ashanul Haque
Journal:  Curr Cancer Drug Targets       Date:  2011-02       Impact factor: 3.428

9.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

Authors:  W L Monsky; D Fukumura; T Gohongi; M Ancukiewcz; H A Weich; V P Torchilin; F Yuan; R K Jain
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

10.  Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.

Authors:  Nathan R Miselis; Zhijin J Wu; Nico Van Rooijen; Agnes B Kane
Journal:  Mol Cancer Ther       Date:  2008-03-28       Impact factor: 6.261

View more
  114 in total

1.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles.

Authors:  Jingwei Ma; Yi Zhang; Ke Tang; Huafeng Zhang; Xiaonan Yin; Yong Li; Pingwei Xu; Yanling Sun; Ruihua Ma; Tiantian Ji; Junwei Chen; Shuang Zhang; Tianzhen Zhang; Shunqun Luo; Yang Jin; Xiuli Luo; Chengyin Li; Hongwei Gong; Zhixiong Long; Jinzhi Lu; Zhuowei Hu; Xuetao Cao; Ning Wang; Xiangliang Yang; Bo Huang
Journal:  Cell Res       Date:  2016-05-10       Impact factor: 25.617

2.  Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages.

Authors:  Yuchun Cao; Chunlei Liu; Zhichao Gu; Yong Zhang; Yi Duan; Yi Zhang; Huafeng Zhang; Ke Tang; Bo Huang
Journal:  Cell Mol Immunol       Date:  2015-04-20       Impact factor: 11.530

3.  The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency.

Authors:  Qingle Liang; Nana Bie; Tuying Yong; Ke Tang; Xiaolong Shi; Zhaohan Wei; Haibo Jia; Xiaoqiong Zhang; Haiyan Zhao; Wei Huang; Lu Gan; Bo Huang; Xiangliang Yang
Journal:  Nat Biomed Eng       Date:  2019-05-20       Impact factor: 25.671

Review 4.  Extracellular vesicles in cardiovascular diseases.

Authors:  Shihui Fu; Yujie Zhang; Yulong Li; Leiming Luo; Yali Zhao; Yao Yao
Journal:  Cell Death Discov       Date:  2020-07-30

5.  Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway.

Authors:  Yanling Sun; Zu'an Zheng; Huafeng Zhang; Yuandong Yu; Jingwei Ma; Ke Tang; Pingwei Xu; Tiantian Ji; Xiaoyu Liang; Degao Chen; Xun Jin; Tianzhen Zhang; Zhixiong Long; Yuying Liu; Bo Huang
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

6.  Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity.

Authors:  Wenqian Dong; Huafeng Zhang; Xiaonan Yin; Yuying Liu; Degao Chen; Xiaoyu Liang; Xun Jin; Jiadi Lv; Jingwei Ma; Ke Tang; Zhuowei Hu; Xiaofeng Qin; Bo Huang
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

Review 7.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

Review 8.  Microparticles: new light shed on the understanding of venous thromboembolism.

Authors:  Lin Zhou; Xiao-long Qi; Ming-xin Xu; Yu Mao; Ming-lin Liu; Hao-ming Song
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

9.  Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cells.

Authors:  Venugopal Thayanithy; Victor Babatunde; Elizabeth L Dickson; Phillip Wong; Sanghoon Oh; Xu Ke; Afsar Barlas; Sho Fujisawa; Yevgeniy Romin; André L Moreira; Robert J Downey; Clifford J Steer; Subbaya Subramanian; Katia Manova-Todorova; Malcolm A S Moore; Emil Lou
Journal:  Exp Cell Res       Date:  2014-01-24       Impact factor: 3.905

10.  TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.

Authors:  Hongliang Fang; Bing Ang; Xinyun Xu; Xiaohui Huang; Yanfeng Wu; Yanping Sun; Wenying Wang; Nan Li; Xuetao Cao; Tao Wan
Journal:  Cell Mol Immunol       Date:  2013-12-23       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.